Alexander Knuth
Overview
Explore the profile of Alexander Knuth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
3784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wan S, Kumar D, Ilyin V, Al Homsi U, Sher G, Knuth A, et al.
Sci Rep
. 2021 Jun;
11(1):13452.
PMID: 34188094
The advent of personalised medicine promises a deeper understanding of mechanisms and therefore therapies. However, the connection between genomic sequences and clinical treatments is often unclear. We studied 50 breast...
2.
Pietge H, Sanchez-Velazquez P, Akhoundova D, Siebenhuner A, Winder T, Bachmann H, et al.
Oncology
. 2021 Mar;
99(5):300-309.
PMID: 33657549
Background: Unresectable cholangiocarcinoma has a poor prognosis and treatment options are limited. Combined systemic and intrahepatic chemotherapy may improve local control and enable downsizing. The aim of this study was...
3.
Roesti E, Boyle C, Zeman D, Sande-Melon M, Storni F, Cabral-Miranda G, et al.
Vaccines (Basel)
. 2020 Mar;
8(1).
PMID: 32131431
Type 2 diabetes mellitus (T2DM) is a chronic progressive disease characterized by insulin resistance and insufficient insulin secretion to maintain normoglycemia. The majority of T2DM patients bear amyloid deposits mainly...
4.
Mohsen M, Speiser D, Knuth A, Bachmann M
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2019 Aug;
12(1):e1579.
PMID: 31456339
Active immunotherapy of cancer aims to treat the disease by inducing effective cellular and humoral immune responses. Virus-like particle-based vaccines have evolved dramatically over the last few decades, greatly reducing...
5.
Mohsen M, Vogel M, Riether C, Muller J, Salatino S, Ternette N, et al.
Front Immunol
. 2019 Jun;
10:1015.
PMID: 31156619
Personalized cancer vaccines hold promises for future cancer therapy. Targeting neoantigens is perceived as more beneficial compared to germline, non-mutated antigens. However, it is a practical challenge to identify and...
6.
Mohsen M, Heath M, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, et al.
J Immunother Cancer
. 2019 May;
7(1):137.
PMID: 31122271
Following publication of the original article [1], the author reported an author's family name has been misspelled. Paul Engroff should be replace Paul Engeroff.Furthermore, there are two mistake in two...
7.
Mohsen M, Heath M, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, et al.
J Immunother Cancer
. 2019 Apr;
7(1):114.
PMID: 31027511
Background: Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for...
8.
Sebastian M, Schroder A, Scheel B, Hong H, Muth A, von Boehmer L, et al.
Cancer Immunol Immunother
. 2019 Feb;
68(5):799-812.
PMID: 30770959
CV9201 is an RNActive-based cancer immunotherapy encoding five non-small cell lung cancer-antigens: New York esophageal squamous cell carcinoma-1, melanoma antigen family C1/C2, survivin, and trophoblast glycoprotein. In a phase I/IIa...
9.
Bengs S, Becker E, Busenhart P, Spalinger M, Raselli T, Kasper S, et al.
Int J Cancer
. 2019 Jan;
145(3):678-685.
PMID: 30653264
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide and the need for novel biomarkers and therapeutic strategies to improve diagnosis and surveillance is obvious. This...
10.
Murner C, Stenner-Liewen F, Seifert B, Mueller N, Schmidt A, Renner C, et al.
Leuk Lymphoma
. 2018 Aug;
60(3):685-695.
PMID: 30126310
Selective digestive decontamination (SDD) with the oral, non-absorbable antimicrobial substances gentamicin, vancomycin and amphotericin B was optionally used at our institution to reduce the risk of gastrointestinal tract derived infections...